Cargando…
Central airway obstruction: is it time to move forward?
INTRODUCTION: Central airway obstruction (CAO) represents a pathological condition that can lead to airflow limitation of the trachea, main stem bronchi, bronchus intermedius or lobar bronchus. MAIN BODY: It is a common clinical situation consensually considered under-diagnosed. Management of patien...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858525/ https://www.ncbi.nlm.nih.gov/pubmed/35183132 http://dx.doi.org/10.1186/s12890-022-01862-x |
_version_ | 1784654259174768640 |
---|---|
author | Guedes, Fernando Branquinho, Mariana V. Sousa, Ana C. Alvites, Rui D. Bugalho, António Maurício, Ana Colette |
author_facet | Guedes, Fernando Branquinho, Mariana V. Sousa, Ana C. Alvites, Rui D. Bugalho, António Maurício, Ana Colette |
author_sort | Guedes, Fernando |
collection | PubMed |
description | INTRODUCTION: Central airway obstruction (CAO) represents a pathological condition that can lead to airflow limitation of the trachea, main stem bronchi, bronchus intermedius or lobar bronchus. MAIN BODY: It is a common clinical situation consensually considered under-diagnosed. Management of patients with CAO can be difficult and deciding on the best treatment approach represents a medical challenge. This work intends to review CAO classifications, causes, treatments and its therapeutic limitations, approaching benign and malign presentations. Three illustrative cases are further presented, supporting the clinical problem under review. CONCLUSION: Management of CAO still remains a challenge. The available options are not always effective nor free from complications. A new generation of costume-tailored airway stents, associated with stem cell-based therapy, could be an option in specific clinical situations. |
format | Online Article Text |
id | pubmed-8858525 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88585252022-02-23 Central airway obstruction: is it time to move forward? Guedes, Fernando Branquinho, Mariana V. Sousa, Ana C. Alvites, Rui D. Bugalho, António Maurício, Ana Colette BMC Pulm Med Research INTRODUCTION: Central airway obstruction (CAO) represents a pathological condition that can lead to airflow limitation of the trachea, main stem bronchi, bronchus intermedius or lobar bronchus. MAIN BODY: It is a common clinical situation consensually considered under-diagnosed. Management of patients with CAO can be difficult and deciding on the best treatment approach represents a medical challenge. This work intends to review CAO classifications, causes, treatments and its therapeutic limitations, approaching benign and malign presentations. Three illustrative cases are further presented, supporting the clinical problem under review. CONCLUSION: Management of CAO still remains a challenge. The available options are not always effective nor free from complications. A new generation of costume-tailored airway stents, associated with stem cell-based therapy, could be an option in specific clinical situations. BioMed Central 2022-02-19 /pmc/articles/PMC8858525/ /pubmed/35183132 http://dx.doi.org/10.1186/s12890-022-01862-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Guedes, Fernando Branquinho, Mariana V. Sousa, Ana C. Alvites, Rui D. Bugalho, António Maurício, Ana Colette Central airway obstruction: is it time to move forward? |
title | Central airway obstruction: is it time to move forward? |
title_full | Central airway obstruction: is it time to move forward? |
title_fullStr | Central airway obstruction: is it time to move forward? |
title_full_unstemmed | Central airway obstruction: is it time to move forward? |
title_short | Central airway obstruction: is it time to move forward? |
title_sort | central airway obstruction: is it time to move forward? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858525/ https://www.ncbi.nlm.nih.gov/pubmed/35183132 http://dx.doi.org/10.1186/s12890-022-01862-x |
work_keys_str_mv | AT guedesfernando centralairwayobstructionisittimetomoveforward AT branquinhomarianav centralairwayobstructionisittimetomoveforward AT sousaanac centralairwayobstructionisittimetomoveforward AT alvitesruid centralairwayobstructionisittimetomoveforward AT bugalhoantonio centralairwayobstructionisittimetomoveforward AT mauricioanacolette centralairwayobstructionisittimetomoveforward |